Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Vir Biotechnology, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 214 | 221 | +7 |
| Shares | 85.8M | 86.9M | +1.06M (+1.2%) |
| Value | $2.20B | $1.68B | −$525.5M (−23.9%) |
New holders (37)
Institutions that held Vir Biotechnology, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (30)
Institutions that held Vir Biotechnology, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.